Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients
2015-001482-57Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colon cancer comparing Aspirin arm with Placebo arm (2 arms). Primary endpoint: Disease-free survival. Started Apr 2016; status: completed.
02
Drugs
aspirin
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2015-001482-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001482-57.